Glioma
Conditions
Interventions
Gold Standard:Histopathological diagnosis results (including histopathological grades and molecular subtypes)
Index test:The terahertz (THz) spectroscopy, Raman spectroscopy, and their fusion technology (THz-Raman)
Sponsors
The First Affiliated Hospital of Army Medical University
Eligibility
Sex/Gender
All
Age
5 Years to 80 Years
Inclusion criteria
Inclusion criteria: 1.Patients diagnosed with glioma at the First Affiliated Hospital of Army Medical University. 2.Patients who have undergone pathological diagnosis and surgery. 3.Postoperative tumor tissue samples meet the requirements for spectral analysis (no significant necrosis, calcification, or other factors affecting the detection). 4.Voluntarily participate in the study and sign an informed consent form.
Exclusion criteria
Exclusion criteria: 1.Patients with unclear pathological diagnosis. 2.Insufficient sample size or poor sample quality (e.g., necrotic tissue > 50%). 3.Patients with known active or chronic HBV or HCV infection accompanied by liver dysfunction. 4.Patients without civil capacity. 5.Patients unable to understand the potential risks and benefits of the study.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| The accuracy under different histopathological grades and molecular subtypes;The specificity under different histopathological grades and molecular subtypes; | — |
Secondary
| Measure | Time frame |
|---|---|
| Sensitivity; | — |
Countries
China
Contacts
Public ContactChentunan
The First Affiliated Hospital of Army Medical University
Outcome results
None listed